Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis

National Medical Journal of China

Volumn 92, Issue 31, 2012, Pages 2182-2187

  Chen, Fang ^a   Shu, Xiao Ming ^b   Wang, Dong Xue ^b   Xie, Yao ^b   Wang, Guo Chun ^b  

^a GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

Lung diseases, interstitial; Myositis; SP A; SP D

Indexed keywords

C REACTIVE PROTEIN; CARBON MONOXIDE; FERRITIN; MONOCYTE CHEMOTACTIC PROTEIN 1; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; INTERSTITIAL LUNG DISEASE; LUNG INFECTION; POLYMYOSITIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DERMATOMYOSITIS; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; POLYMYOSITIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; YOUNG ADULT;

EID: 84869204729     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2012.31.009     Document Type: Article

References (13)

1. Saketkoo L A, Ascherman D P, Cottin V, et al. Interstitial lung disease in idiopathic inflammatory myopathy. Curr Rheumatol Rev, 2010, 22: 633-638.
2. Hermans C, Bernard A. Lung epithelium-specific proteins. Characteristics and potential applications as markers. Am J Respir Crit Care Med, 1999, 159: 646-678.
3. Ihn H, Asano Y, Kubo M, et al. Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermato myositis: correlation with interstitial lung disease. Rheumatology, 2002, 41: 1268-1272.
4. Marie I, Hachulla E, Cherin P, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum, 2002, 47: 614-622.
5. 2003, 83: 1565-1568.
6. Kubo M, Ihn H, Yamane K, et al. Serum KL-6 in adult patients with polymyositis and dermatomyositis. Rheumatology, 2000, 39: 632-636.
7. 2006, 10: 416-419.
8. Ishii H, Mukae H, Kadota J, et al. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax, 2003, 58: 52-57.
9. Chroneos Z C, Chroneos Z S, Shepherd V L. Pulmonary Surfactant: An Immunological Perspective. Cell Physiol Biochem, 2010, 25: 13-26.
10. Ohnishi H, Yokoyama A, Kondo K, et al. Comparative Study of KL-6, Surfactant Protein-A, Surfactant Protein-D, and Monocyte Chemoattractant Protein-1 as Serum Markers for Interstitial Lung Diseases. Am J Resp Crit Care, 2002, 165: 378-381.
11. 2009, 13: 320-323.
12. Kumánovics G, Minier T, Radics J, et al. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis. Clin Exp Rheumatol, 2008, 26: 414-420.
13. Al-Salmi Q A, Walter J N, Colasurdo G N, et al. Serum KL-6 and surfactant proteins a and D in pediatric interstitial lung disease. Chest, 2005, 127: 403-407.